Pharmaceutical Facility Management – New Book Released
The new second edition of this bestselling book is bigger, better and takes the reader to the next level and future ready. While the earlier edition was all about smooth and troublefree working of a pharmaceutical facility, the new second edition strives to achieve excellence and set industry benchmarks for facilities of the future. The pharmaceutical facilities of today must reach out beyond the routine and strive for excellence in all spheres of activity, to enable the company retain its competitive edge in the marketplace. To put the facility manager firmly in control of the entire facility, a new chapter has been created specifically to focus on facility manager and the roles and responsibilities that compose the job description of this position.
Social responsibility towards the planet we inhabit has been recognized as our unfailing duty and ways to sustain the ecosystem are constantly being evolved. Since pharmaceutical manufacturing facilities impose lots of demands on the physical environment in which they exist, innovative companies are always trying to lessen their carbon footprint through various methodologies being evolved. What is today seen as innovation will perhaps become mandatory in the near future and hence a new chapter has been introduced called ‘Sustainable Facilities’ that suggests various means by which a company can reduce its carbon footprint.
The most exciting change however in the new edition is the introduction of a new chapter, ‘Operational Excellence in Pharma Manufacturing’ which focuses on manufacturing efficiency for the first time, focusing on actual shop floor strategies rather than arcane management fuzzy logic formulas. While current efficiency levels in the pharmaceutical industry are examined, avenues for excellence are explored that include continuous processing of pharmaceuticals, automated manufacturing, optimizing batch sizes and cycle times and overall equipment effectiveness (OEE). A company can thus develop its own corporate manufacturing strategy based on the technology level it is willing to upgrade to, market and business demands and the resources required for such project.
All other chapters have been thoroughly overhauled, outdated information removed and current and up-to-date information included to transform the existing chapters to cutting edge contemporary standards.
The author JPS Kohli is a pharmacy graduate from University of Delhi followed by Diploma in Management of Technology Transfer, Patents and Information Systems. He has wide ranging experience in the pharmaceutical industry, having worked in a pharmaceutical engineering company followed by working in a pharmaceutical manufacturing facility as Manager-Projects and Exports. He is a member of Indian Pharmaceutical Association (IPA), International Society of Pharmaceutical Engineers (ISPE), American Association of Pharmaceutical Scientists (AAPS), Pharmaceutical and Healthcare Sciences Society (PHSS) and International Federation of Pharmaceuticals (FIP). He is included in Who’s Who in the field of Science and Engineering. He has travelled extensively and visited/audited the manufacturing plants of many companies. He now heads the firm Business Horizons that specializes in books on pharmaceuticals and herbal medicines with an emphasis on technical and quality aspects.
For details visit www.businesshorizons.com or contact email@example.com for further information.
Business Horizons, Pharmaceutical Publishers, are leading publishers of technical books for the pharmaceuticals and herbal medicine industry, being sold in over 80 countries worldwide.
G-59, Masjid Moth, GK-2, New Delhi 110048, INDIA
Tel: +91 921206 1554
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmaceutical Facility Management – New Book Released here
News-ID: 275641 • Views: 3619
More Releases from Business Horizons
PHARMA MANUFACTURING COVID-19 CHALLENGE
New Delhi, 19 June, 2020 - Business Horizons, pharmaceutical publishers, announces the launch of their latest publication titled Pharma Manufacturing Covid-19 Challenge. This is their latest offering in the field of pharmaceutical books, after the highly successful earlier book Pharmaceutical Facility Management. In December 2019, China began noticing a disturbing trend of pneumonia like cases that were fast multiplying in the city of Wuhan, the sprawling capital of central China’s Hubei
Achieving Quality and Compliance Excellence in Pharmaceuticals - New Book Releas …
In todays contemporary pharmaceutical industry, the focus has slowly but surely shifted from the elusive research pipeline and latest blockbuster molecules to current processes, efficiencies and manufacturing systems. A path most often taken by manufacturers today in this direction includes improving their overall quality and compliance efforts. This results in a two-pronged approach of minimizing the litigation cost and concurrently improving the overall quality of the products and efficiencies in
More Releases for Pharma
Global Deferasirox Market 2018 - Novartis, Cipla, Sun Pharma, Natco Pharma
Apex Market Reports, recently published a detailed market research study focused on the “Deferasirox Market” across the global, regional and country level. The report provides 360° analysis of “Deferasirox Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Deferasirox on the basis of
Big Pharma Outlook 2026
Boston, MA ReportsWorldwide has announced the addition of a new report title Big Pharma Outlook 2026 to its growing collection of premium market research reports. Pharmavitae Analytics casts its eye out to 2026 with challenging trends in healthcare management set to crystallize, Big Pharma will add $29.5bn in revenues out to 2026, generating $351bn in prescription pharmaceuticals at a low single-digit compound annual growth rate (CAGR) of 0.9%. Using in-house sales forecasts,
Erythrocyte Catalase Market 2017 - Sanofi, Palam Pharma, Bioxera, Zafax Pharma
Apex Research, recently published a detailed market research study focused on the "Erythrocyte Catalase Market" across the global, regional and country level. The report provides 360° analysis of "Erythrocyte Catalase Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Erythrocyte Catalase industry, and estimates the future trend of Erythrocyte Catalase market on
12th World Pharma Congress
Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting in an abundant knowledge of the mechanisms driving drug discovery and development. Pharmaceutical Formulation Market size was USD $147billion in 2015 and is anticipated to reach around USD 175.1 billion by 2018. In USA, the total number of new drugs approved between
12th World Pharma Congress
Conference Series has taken an initiation to conduct International Pharma Congress worldwide. From several years Conference Series has been conducting Pharma Congress conferences in major continents like Europe, America and Asia Pacific. Previous conferences were held in city like USA, with success. Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting
4th African Pharma Congress
In the light of this theme, the conference series aims to provide a forum for international researchers from various areas of pharmaceutical sciences like chemical processing, industrial practice, analytical methods and pharmacological actions by providing a platform for critical analysis of new agenda, and to share latest cutting-edge research findings and results about all aspects of Pharmacy We are honoured to invite pharmacists, researchers, professors, scientific communities, delegates, students, business